RAVENSBURG, Germany–(BUSINESS WIRE)–Vetter, one of the world’s leading pharmaceutical service providers for the production of injectable drugs, has confirmed its plans to build a state-of-the-art production facility in the Saarland region of southwest Germany. This strategic investment marks a significant milestone in the company’s long-term global growth strategy. Construction is scheduled to begin in the second quarter of 2026. Initially, approximately €480 million have been allocated for the first construction phase of the new…
Source link
Pharmaceutical Service Provider Vetter Pharma to Build New Manufacturing Site in Germany
